LUX-Lung 4: A Phase II Trial of Afatinib in Patients withAdvanced, Non-Small Cell Lung Cancer who progressed on Prior Treatment with Erlotinib, Gefitinib, or Both
LUX-Lung 4: A Phase II Trial of Afatinib in Patients withAdvanced, Non-Small Cell Lung Cancer who progressed on Prior Treatment with Erlotinib, Gefitinib, or Both
复制标题
LUX-Lung 4：阿法替尼治疗晚期非小细胞肺癌患者的 II 期试验，这些患者先前接受厄洛替尼、吉非替尼或两者治疗后病情进展
作者：
Katakami N;Atagi S;Inoue A;et al
